PT  - JOURNAL ARTICLE
AU  - Eryarsoy, Enes
AU  - Delen, Dursun
AU  - Davazdahemami, Behrooz
TI  - Adjusting COVID-19 Reports for Countries’ Age Disparities: A Comparative Framework for Reporting Performances
AID  - 10.1101/2020.08.31.20185223
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.31.20185223
4099  - http://medrxiv.org/content/early/2020/09/02/2020.08.31.20185223.short
4100  - http://medrxiv.org/content/early/2020/09/02/2020.08.31.20185223.full
AB  - Objectives The COVID-19 outbreak has impacted distinct health care systems differently. While the rate of disease for COVID-19 is highly age-variant, there is no unified and age/gender-inclusive reporting taking place. This renders the comparison of individual countries based on their corresponding metrics, such as CFR difficult. In this paper, we examine cross-country differences, in terms of the age distribution of symptomatic cases, hospitalizations, intensive care unit (ICU) cases, and fatalities. In addition, we propose a new quality measure (called dissonance ratio) to facilitate comparison of countries’ performance in testing and reporting COVID-19 cases (i.e., their reporting quality).Methods By combining population pyramids with estimated COVID-19 age-dependent conditional probabilities, we bridge country-level incidence data gathered from different countries and attribute the variability in data to country demographics.Results We show that age-adjustment can account for as much as a 22-fold difference in the expected number of fatalities across different countries. We provide case, hospitalization, ICU, and fatality breakdown estimates for a comprehensive list of countries. Also, a comparison is conducted between countries in terms of their performance in reporting COVID-19 cases and fatalities.Conclusions Our research sheds light on the importance of and propose a methodology to use countries’ population pyramids for obtaining accurate estimates of the healthcare system requirements based on the experience of other, already affected, countries at the time of pandemics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe research received no funding from any sources.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yes-